• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烦躁型经前综合征女性的状态和特质血清素能异常。

State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes.

作者信息

Kouri E M, Halbreich U

机构信息

Biological Psychiatry Laboratory, McLean Hospital/Harvard Medical School, Belmont, MA, USA.

出版信息

Psychopharmacol Bull. 1997;33(4):767-70.

PMID:9493490
Abstract

Three to eight percent of women of reproductive age suffer from dysphoric premenstrual disorder (PMS). Although the exact pathophysiology of this disorder is not known, serotonergic dysregulation appears to be involved. In this article, we review and summarize the current data on changes in serotonergic parameters in women with dysphoric PMS and emphasize the distinction between state-related abnormalities which are present only during the symptomatic late-luteal phase and trait abnormalities which are present even during non-symptomatic phases of the menstrual cycle. The notion of diversified serotonergic systems that are selectively affected by fluctuations in gonadal hormones is discussed in the context of PMS as well as other dysphorias.

摘要

3%至8%的育龄女性患有经前烦躁障碍(PMS)。尽管这种疾病的确切病理生理学尚不清楚,但血清素调节异常似乎与之相关。在本文中,我们回顾并总结了目前关于经前烦躁障碍女性血清素参数变化的数据,并强调仅在有症状的黄体晚期出现的与状态相关的异常和即使在月经周期无症状阶段也存在的特质异常之间的区别。在经前烦躁障碍以及其他烦躁症的背景下,讨论了性腺激素波动选择性影响的多样化血清素系统的概念。

相似文献

1
State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes.烦躁型经前综合征女性的状态和特质血清素能异常。
Psychopharmacol Bull. 1997;33(4):767-70.
2
[Neurochemical background of the premenstrual syndrome: the role of the serotonergic system].[经前综合征的神经化学背景:血清素能系统的作用]
Neuropsychopharmacol Hung. 2004 Oct;6(3):153-62.
3
Altered serotonergic activity in women with dysphoric premenstrual syndromes.烦躁型经前综合征女性的血清素能活性改变。
Int J Psychiatry Med. 1993;23(1):1-27. doi: 10.2190/J2W0-RTGD-NYKK-FF77.
4
[Diagnostic and therapeutic algorithm for the treatment of premenstrual dysphoric disorder].[经前期烦躁障碍的诊断与治疗算法]
Acta Med Croatica. 2010 Jul;64(3):183-90.
5
Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.经前烦躁障碍女性体内胰岛素样生长因子-1浓度较低。
Am J Obstet Gynecol. 2008 May;198(5):506.e1-8. doi: 10.1016/j.ajog.2007.11.005. Epub 2008 Jan 15.
6
Psychological aspects of premenstrual syndrome.经前综合征的心理方面
Best Pract Res Clin Obstet Gynaecol. 2007 Apr;21(2):207-20. doi: 10.1016/j.bpobgyn.2006.10.002. Epub 2006 Dec 15.
7
Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorders.无经前烦躁障碍的健康女性在整个生殖周期中的情绪变化模式。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1782-8. doi: 10.1016/j.pnpbp.2008.07.016. Epub 2008 Jul 30.
8
Late luteal phase dysphoric disorder (premenstrual syndromes): clinical implications.
J Clin Psychiatry. 1988 Dec;49(12):469-73.
9
Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.经前期烦躁障碍患者对芬氟拉明激发试验的血清素反应迟钝。
Am J Psychiatry. 1997 Apr;154(4):556-8. doi: 10.1176/ajp.154.4.556.
10
Diagnosis and treatment of premenstrual dysphoric disorder: an update.经前烦躁障碍的诊断与治疗:最新进展
Int Clin Psychopharmacol. 2000 Nov;15 Suppl 3:S5-17.

引用本文的文献

1
IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.色氨酸和色氨酸代谢产物(TRYCATs)的 IgA/IgM 反应与产前抑郁、足月时的生理躯体症状和经前期综合征的相关性不同。
Mol Neurobiol. 2017 May;54(4):3038-3049. doi: 10.1007/s12035-016-9877-3. Epub 2016 Apr 1.
2
Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?经前期综合征/经前期烦躁障碍的不同药物治疗所改善的症状特征是否存在差异?
CNS Drugs. 2006;20(7):523-47. doi: 10.2165/00023210-200620070-00001.
3
Premenstrual Dysphoric Disorder: Recognition and Treatment.
经前烦躁障碍:识别与治疗
Prim Care Companion J Clin Psychiatry. 2003 Feb;5(1):30-39. doi: 10.4088/pcc.v05n0106.
4
The role of hormones and hormonal treatments in premenstrual syndrome.激素及激素治疗在经前综合征中的作用。
CNS Drugs. 2003;17(5):325-42. doi: 10.2165/00023210-200317050-00003.
5
The pathophysiologic background for current treatments of premenstrual syndromes.
Curr Psychiatry Rep. 2002 Dec;4(6):429-34. doi: 10.1007/s11920-002-0070-1.
6
The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.中枢5-羟色胺能功能障碍在经前烦躁障碍病因学中的作用:治疗意义。
CNS Drugs. 2001;15(4):277-85. doi: 10.2165/00023210-200115040-00003.